Penumbra
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.About PEN
Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system.
PEN Key Statistics
Stock Snapshot
With a market cap of 10.33B, Penumbra(PEN) trades at $264.61. The stock has a price-to-earnings ratio of 63.24.
On 2025-11-07, Penumbra(PEN) stock moved within a range of $258.88 to $272.00. With shares now at $264.61, the stock is trading +2.2% above its intraday low and -2.7% below the session's peak.
Trading activity shows a volume of 1.1M, compared to an average daily volume of 559.76K.
The stock's 52-week range extends from a low of $221.26 to a high of $310.00.
The stock's 52-week range extends from a low of $221.26 to a high of $310.00.
PEN News
Penumbra Inc. ((PEN)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst...
Image source: The Motley Fool. Wednesday, November 5, 2025, at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Adam Elsesser Chief Financial Officer —...
Penumbra (PEN) stock skyrocketed Thursday, coming within striking distance of a breakout, after the medtech company beat third-quarter expectations on the back...
Analyst ratings
85%
of 20 ratingsMore PEN News
Analyst Patrick Wood of Morgan Stanley maintained a Hold rating on Penumbra, with a price target of $266.00. Meet Your ETF AI Analyst Discover how TipRanks' ETF...
Penumbra Inc. ( (PEN) ) has released its Q3 earnings. Here is a breakdown of the information Penumbra Inc. presented to its investors. Meet Your ETF AI Analyst...
Earnings Call Insights Penumbra raises 2025 revenue guidance to $1.375B–$1.38B as CAVT and embolization drive growth Nov. 05, 2025 7:32 PM ET Penumbra, Inc. (PE...
